Your browser doesn't support javascript.
loading
DNA methylation-based prognostic subtypes of chordoma tumors in tissue and plasma.
Zuccato, Jeffrey A; Patil, Vikas; Mansouri, Sheila; Liu, Jeffrey C; Nassiri, Farshad; Mamatjan, Yasin; Chakravarthy, Ankur; Karimi, Shirin; Almeida, Joao Paulo; Bernat, Anne-Laure; Hasen, Mohammed; Singh, Olivia; Khan, Shahbaz; Kislinger, Thomas; Sinha, Namita; Froelich, Sébastien; Adle-Biassette, Homa; Aldape, Kenneth D; De Carvalho, Daniel D; Zadeh, Gelareh.
Afiliación
  • Zuccato JA; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.
  • Patil V; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
  • Mansouri S; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.
  • Liu JC; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.
  • Nassiri F; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.
  • Mamatjan Y; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.
  • Chakravarthy A; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
  • Karimi S; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.
  • Almeida JP; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Bernat AL; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.
  • Hasen M; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
  • Singh O; Neurosurgery Department, Hôpital Lariboisiere, APHP, Université Paris Diderot, Paris, France.
  • Khan S; Section of Neurosurgery, Division of Surgery, Rady Faculty of Health Science, University of Manitoba, Winnipeg, Canada.
  • Kislinger T; Department of Neurosurgery, King Fahad University Hospital, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
  • Sinha N; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.
  • Froelich S; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Adle-Biassette H; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Aldape KD; Department of Pathology, Shared Health, HSC, University of Manitoba, Winnipeg, Manitoba, Canada.
  • De Carvalho DD; Neurosurgery Department, Hôpital Lariboisiere, APHP, Université Paris Diderot, Paris, France.
  • Zadeh G; Department of Pathology, Lariboisière Hospital, Assistance Publique - Hôpitaux de Paris, Université de Paris, Paris, France.
Neuro Oncol ; 24(3): 442-454, 2022 03 12.
Article en En | MEDLINE | ID: mdl-34614192

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cordoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cordoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido